{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:07:52Z","timestamp":1767373672523,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04410-9","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T05:02:06Z","timestamp":1718859726000},"page":"4257-4263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous liver-directed therapies of intrahepatic cholangiocarcinoma"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6366-7222","authenticated-orcid":false,"given":"Brian","family":"Morse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"McGettigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-650X","authenticated-orcid":false,"given":"Bela","family":"Kis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"4410_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.08.052","author":"MC Bragazzi","year":"2023","unstructured":"M. C. Bragazzi, R. Venere, E. Ribichini, F. Covotta, V. Cardinale, and D. Alvaro, \u2018Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment\u2019, Digestive and Liver Disease. Elsevier B.V., Mar. 01, 2023. doi: https:\/\/doi.org\/10.1016\/j.dld.2023.08.052.","journal-title":"Digestive and Liver Disease."},{"key":"4410_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331480","author":"R Toth","year":"2024","unstructured":"R. Toth, P. J. Brindley, and J. Vaquero, \u2018Enhancing the opportunities for cholangiocarcinoma precision therapy\u2019, Gut. BMJ Publishing Group, 2024. doi: https:\/\/doi.org\/10.1136\/gutjnl-2023-331480.","journal-title":"Gut"},{"key":"4410_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00300-2","author":"PJ Brindley","year":"2021","unstructured":"P. J. Brindley et al., \u2018Cholangiocarcinoma\u2019, Nature Reviews Disease Primers, vol. 7, no. 1. Nature Research, Dec. 01, 2021. doi: https:\/\/doi.org\/10.1038\/s41572-021-00300-2.","journal-title":"Nature Reviews Disease Primers"},{"issue":"2","key":"4410_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/LIFE14020217","volume":"14","author":"G Woodhead","year":"2024","unstructured":"G. Woodhead, S. Lee, L. Struycken, D. Goldberg, J. Hannallah, and S. Young, \u2018Interventional Radiology Locoregional Therapies for Intrahepatic Cholangiocarcinoma\u2019, Life (Basel), vol. 14, no. 2, p. 217, Feb. 2024, doi: https:\/\/doi.org\/10.3390\/LIFE14020217.","journal-title":"Life (Basel)"},{"key":"4410_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1073274817729244","author":"B Kis","year":"2017","unstructured":"B. Kis et al., \u2018Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma\u2019, Cancer Control, vol. 24, no. 3. SAGE Publications Ltd, Sep. 06, 2017. doi: https:\/\/doi.org\/10.1177\/1073274817729244.","journal-title":"Cancer Control"},{"issue":"5","key":"4410_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"S. K. Saha, A. X. Zhu, C. S. Fuchs, and G. A. Brooks, \u2018Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise\u2019, Oncologist, vol. 21, no. 5, pp. 594\u2013599, May 2016, doi: https:\/\/doi.org\/10.1634\/theoncologist.2015-0446.","journal-title":"Oncologist"},{"key":"4410_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2310196","author":"Y Li","year":"2024","unstructured":"Y. Li, J. Yu, Y. Zhang, C. Peng, Y. Song, and S. Liu, \u2018Advances in targeted therapy of cholangiocarcinoma\u2019, Annals of Medicine, vol. 56, no. 1. Taylor and Francis Ltd., 2024. doi: https:\/\/doi.org\/10.1080\/07853890.2024.2310196.","journal-title":"Annals of Medicine"},{"key":"4410_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1321683","author":"SM Ruff","year":"2024","unstructured":"S. M. Ruff and T. M. Pawlik, \u2018Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies\u2019, Frontiers in Oncology, vol. 14. Frontiers Media SA, 2024. doi: https:\/\/doi.org\/10.3389\/fonc.2024.1321683.","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"4410_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/JSO.23605","volume":"110","author":"N Amini","year":"2014","unstructured":"N. Amini, A. Ejaz, G. Spolverato, Y. Kim, J. M. Herman, and T. M. Pawlik, \u2018Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis\u2019, J Surg Oncol, vol. 110, no. 2, pp. 163\u2013170, 2014, doi: https:\/\/doi.org\/10.1002\/JSO.23605.","journal-title":"Journal of Surgical Oncology"},{"issue":"1","key":"4410_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/S10434-015-4642-9","volume":"23","author":"G Spolverato","year":"2016","unstructured":"G. Spolverato et al., \u2018Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection\u2019, Ann Surg Oncol, vol. 23, no. 1, pp. 235\u2013243, Jan. 2016, doi: https:\/\/doi.org\/10.1245\/S10434-015-4642-9.","journal-title":"Annals of Surgical Oncology"},{"issue":"4","key":"4410_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-0039-1696649","volume":"36","author":"J Sweeney","year":"2019","unstructured":"J. Sweeney, N. Parikh, G. El-Haddad, and B. Kis, \u2018Ablation of Intrahepatic Cholangiocarcinoma\u2019, Semin Intervent Radiol, vol. 36, no. 4, pp. 298\u2013302, 2019, doi: https:\/\/doi.org\/10.1055\/s-0039-1696649.","journal-title":"Seminars in Interventional Radiology"},{"key":"4410_CR12","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDOA2200015","author":"DY Oh","year":"2022","unstructured":"D.-Y. Oh et al., \u2018Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer\u2019, NEJM Evidence, vol. 1, no. 8, Jun. 2022, doi: https:\/\/doi.org\/10.1056\/EVIDOA2200015.","journal-title":"NEJM Evidence"},{"key":"4410_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS15092655","author":"TA Auer","year":"2023","unstructured":"T. A. Auer et al., \u2018Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma\u2019, Cancers (Basel), vol. 15, no. 9, May 2023, doi: https:\/\/doi.org\/10.3390\/CANCERS15092655.","journal-title":"Cancers (Basel)"},{"key":"4410_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/MEDICINA59071186","author":"G Charalampopoulos","year":"2023","unstructured":"G. Charalampopoulos et al., \u2018Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma\u2019, Medicina (Kaunas), vol. 59, no. 7, Jul. 2023, doi: https:\/\/doi.org\/10.3390\/MEDICINA59071186.","journal-title":"Medicina"},{"issue":"5","key":"4410_CR15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/J.JVIR.2012.01.081","volume":"23","author":"Y Fu","year":"2012","unstructured":"Y. Fu, W. Yang, W. Wu, K. Yan, B. C. Xing, and M. H. Chen, \u2018Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma\u2019, J Vasc Interv Radiol, vol. 23, no. 5, pp. 642\u2013649, 2012, doi: https:\/\/doi.org\/10.1016\/J.JVIR.2012.01.081.","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"7","key":"4410_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/J.JVIR.2015.02.024","volume":"26","author":"K Han","year":"2015","unstructured":"K. Han, H. K. Ko, K. W. Kim, H. J. Won, Y. M. Shin, and P. N. Kim, \u2018Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis\u2019, J Vasc Interv Radiol, vol. 26, no. 7, pp. 943\u2013948, Jul. 2015, doi: https:\/\/doi.org\/10.1016\/J.JVIR.2015.02.024.","journal-title":"Journal of Vascular and Interventional Radiology"},{"key":"4410_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.671327","author":"H Li","year":"2021","unstructured":"H. Li, L. Chen, G. Y. Zhu, X. Yao, R. Dong, and J. H. Guo, \u2018Interventional Treatment for Cholangiocarcinoma\u2019, Front Oncol, vol. 11, Jun. 2021, doi: https:\/\/doi.org\/10.3389\/FONC.2021.671327.","journal-title":"Frontiers in Oncology"},{"key":"4410_CR18","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2023.71","author":"R Bale","year":"2023","unstructured":"R. Bale and T. M. Pawlik, \u2018Treatment of intrahepatic cholangiocarcinoma: evidence for the role of percutaneous ablation\u2019, Hepatoma Res, vol. 9, no. 0, p. null-null, Oct. 2023, doi: https:\/\/doi.org\/10.20517\/2394-5079.2023.71.","journal-title":"Hepatoma Research"},{"key":"4410_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS15082384","author":"M Owen","year":"2023","unstructured":"M. Owen, M. S. Makary, and E. W. Beal, \u2018Locoregional Therapy for Intrahepatic Cholangiocarcinoma\u2019, Cancers (Basel), vol. 15, no. 8, Apr. 2023, doi: https:\/\/doi.org\/10.3390\/CANCERS15082384.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4410_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/02656736.2017.1327678","volume":"34","author":"K Zhang","year":"2018","unstructured":"K. Zhang et al., \u2018Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma\u2019, Int J Hyperthermia, vol. 34, no. 3, pp. 292\u2013297, Apr. 2018, doi: https:\/\/doi.org\/10.1080\/02656736.2017.1327678.","journal-title":"International Journal of Hyperthermia"},{"issue":"4","key":"4410_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.14218\/JCTH.2019.00036","volume":"7","author":"A Giorgio","year":"2019","unstructured":"A. Giorgio et al., \u2018Intrahepatic Cholangiocarcinoma and Thermal Ablation: Long-term Results of An Italian Retrospective Multicenter Study\u2019, J Clin Transl Hepatol, vol. 7, no. 4, pp. 287\u2013292, 2019, doi: https:\/\/doi.org\/10.14218\/JCTH.2019.00036.","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"1","key":"4410_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/02656736.2019.1571247","volume":"36","author":"C Xu","year":"2019","unstructured":"C. Xu et al., \u2018Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results\u2019, Int J Hyperthermia, vol. 36, no. 1, pp. 351\u2013358, Jan. 2019, doi: https:\/\/doi.org\/10.1080\/02656736.2019.1571247.","journal-title":"International Journal of Hyperthermia"},{"key":"4410_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/S12032-020-01360-2","author":"MP Belfiore","year":"2020","unstructured":"M. P. Belfiore et al., \u2018Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy\u2019, Med Oncol, vol. 37, no. 5, May 2020, doi: https:\/\/doi.org\/10.1007\/S12032-020-01360-2.","journal-title":"Medical Oncology"},{"issue":"1","key":"4410_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/HEP.0000000000000561","volume":"79","author":"I Bargellini","year":"2024","unstructured":"I. Bargellini, L. Rimassa, and G. Masi, \u2018SIRT and chemotherapy in unresectable iCCA: Ready to take off\u2019, Hepatology, vol. 79, no. 1. Wolters Kluwer Medknow Publications, pp. 9\u201311, Jan. 01, 2024. doi: https:\/\/doi.org\/10.1097\/HEP.0000000000000561.","journal-title":"Hepatology"},{"issue":"6","key":"4410_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/J.JVIR.2022.02.016","volume":"33","author":"DA Schartz","year":"2022","unstructured":"D. A. Schartz et al., \u2018Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis\u2019, J Vasc Interv Radiol, vol. 33, no. 6, pp. 679\u2013686, Jun. 2022, doi: https:\/\/doi.org\/10.1016\/J.JVIR.2022.02.016.","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"4","key":"4410_CR26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/J.CRAD.2010.11.002","volume":"66","author":"SY Park","year":"2011","unstructured":"S. Y. Park, J. H. Kim, H. J. Yoon, I. S. Lee, H. K. Yoon, and K. P. Kim, \u2018Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma\u2019, Clin Radiol, vol. 66, no. 4, pp. 322\u2013328, Apr. 2011, doi: https:\/\/doi.org\/10.1016\/J.CRAD.2010.11.002.","journal-title":"Clinical Radiology"},{"issue":"9","key":"4410_CR27","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1245\/S10434-022-12022-0","volume":"29","author":"RCG Martin","year":"2022","unstructured":"R. C. G. Martin et al., \u2018ASO Visual Abstract: Drug-Eluting Beads with Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin\u2019, Ann Surg Oncol, vol. 29, no. 9, pp. 5474\u20135475, Sep. 2022, doi: https:\/\/doi.org\/10.1245\/S10434-022-12022-0.","journal-title":"Annals of Surgical Oncology"},{"issue":"2","key":"4410_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/JNCI\/DJZ071","volume":"112","author":"A Lamarca","year":"2020","unstructured":"A. Lamarca et al., \u2018Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials\u2019, J Natl Cancer Inst, vol. 112, no. 2, pp. 200\u2013210, Feb. 2020, doi: https:\/\/doi.org\/10.1093\/JNCI\/DJZ071.","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"4410_CR29","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/J.IJROBP.2004.09.004","volume":"60","author":"AS Kennedy","year":"2004","unstructured":"A. S. Kennedy, C. Nutting, D. Coldwell, J. Gaiser, and C. Drachenberg, \u2018Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers\u2019, Int J Radiat Oncol Biol Phys, vol. 60, no. 5, pp. 1552\u20131563, Dec. 2004, doi: https:\/\/doi.org\/10.1016\/J.IJROBP.2004.09.004.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"2","key":"4410_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/NRCLINONC.2010.153","volume":"8","author":"B Morgan","year":"2011","unstructured":"B. Morgan, A. S. Kennedy, V. Lewington, B. Jones, and R. A. Sharma, \u2018Intra-arterial brachytherapy of hepatic malignancies: watch the flow\u2019, Nat Rev Clin Oncol, vol. 8, no. 2, pp. 115\u2013120, Feb. 2011, doi: https:\/\/doi.org\/10.1038\/NRCLINONC.2010.153.","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"6","key":"4410_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/J.DIII.2014.03.014","volume":"96","author":"G Vesselle","year":"2015","unstructured":"G. Vesselle, I. Petit, S. Boucebci, T. Rocher, S. Velasco, and J. P. Tasu, \u2018Radioembolization with yttrium-90 microspheres work up: Practical approach and literature review\u2019, Diagn Interv Imaging, vol. 96, no. 6, pp. 547\u2013562, Jun. 2015, doi: https:\/\/doi.org\/10.1016\/J.DIII.2014.03.014.","journal-title":"Diagnostic and Interventional Imaging"},{"issue":"2","key":"4410_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2967\/jnumed.123.265597","volume":"65","author":"MEHM Wagemans","year":"2024","unstructured":"M. E. H. M. Wagemans et al., \u2018Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma\u2019, J Nucl Med, vol. 65, no. 2, pp. 272\u2013278, Feb. 2024, doi: https:\/\/doi.org\/10.2967\/jnumed.123.265597.","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"4410_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/JAMAONCOL.2019.3702","volume":"6","author":"J Edeline","year":"2020","unstructured":"J. Edeline et al., \u2018Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial\u2019, JAMA Oncol, vol. 6, no. 1, pp. 51\u201359, Jan. 2020, doi: https:\/\/doi.org\/10.1001\/JAMAONCOL.2019.3702.","journal-title":"JAMA Oncology"},{"issue":"1","key":"4410_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/HEP.0000000000000544","volume":"79","author":"J Edeline","year":"2024","unstructured":"J. Edeline et al., \u2018Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials\u2019, Hepatology, vol. 79, no. 1, pp. 96\u2013106, Jan. 2024, doi: https:\/\/doi.org\/10.1097\/HEP.0000000000000544.","journal-title":"Hepatology"},{"issue":"8","key":"4410_CR35","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jvir.2018.04.001","volume":"29","author":"A Gangi","year":"2018","unstructured":"A. Gangi et al., \u2018Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study\u2019, Journal of Vascular and Interventional Radiology, vol. 29, no. 8, pp. 1101\u20131108, Aug. 2018, doi: https:\/\/doi.org\/10.1016\/j.jvir.2018.04.001.","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"8","key":"4410_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/S00270-022-03183-2","volume":"45","author":"AN Gupta","year":"2022","unstructured":"A. N. Gupta et al., \u2018Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort\u2019, Cardiovasc Intervent Radiol, vol. 45, no. 8, pp. 1117\u20131128, Aug. 2022, doi: https:\/\/doi.org\/10.1007\/S00270-022-03183-2.","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"9","key":"4410_CR37","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.jvir.2023.05.026","volume":"34","author":"B Kis","year":"2023","unstructured":"B. Kis et al., \u2018Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma\u2014A Prospective Feasibility Study\u2019, Journal of Vascular and Interventional Radiology, vol. 34, no. 9, pp. 1547\u20131555, Sep. 2023, doi: https:\/\/doi.org\/10.1016\/j.jvir.2023.05.026.","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"5","key":"4410_CR38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/J.JCEH.2022.03.008","volume":"12","author":"P Kumar","year":"2022","unstructured":"P. Kumar et al., \u2018Unresectable Intrahepatic Cholangiocarcinoma Treated with Radiation Segmentectomy\/Lobectomy Using Yttrium 90-labeled Glass Microspheres\u2019, J Clin Exp Hepatol, vol. 12, no. 5, pp. 1259\u20131263, Sep. 2022, doi: https:\/\/doi.org\/10.1016\/J.JCEH.2022.03.008.","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"20","key":"4410_CR39","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.18632\/ONCOTARGET.28060","volume":"12","author":"R Paz-Fumagalli","year":"2021","unstructured":"R. Paz-Fumagalli et al., \u2018Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma\u2019, Oncotarget, vol. 12, no. 20, pp. 2075\u20132088, Sep. 2021, doi: https:\/\/doi.org\/10.18632\/ONCOTARGET.28060.","journal-title":"Oncotarget"},{"issue":"8","key":"4410_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jvir.2013.03.019","volume":"24","author":"CE Ray","year":"2013","unstructured":"C. E. Ray et al., \u2018Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma\u2019, Journal of Vascular and Interventional Radiology, vol. 24, no. 8, pp. 1218\u20131226, 2013, doi: https:\/\/doi.org\/10.1016\/j.jvir.2013.03.019.","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"5","key":"4410_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/cbr.2017.2189","volume":"32","author":"NC Swinburne","year":"2017","unstructured":"N. C. Swinburne et al., \u2018Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety, Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival\u2019, Cancer Biother Radiopharm, vol. 32, no. 5, pp. 161\u2013168, Jun. 2017, doi: https:\/\/doi.org\/10.1089\/cbr.2017.2189.","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"issue":"2","key":"4410_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/J.JVIR.2013.10.056","volume":"25","author":"JC Camacho","year":"2014","unstructured":"J. C. Camacho, N. Kokabi, M. Xing, H. J. Prajapati, B. El-Rayes, and H. S. Kim, \u2018Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization\u2019, J Vasc Interv Radiol, vol. 25, no. 2, pp. 256\u2013265, Feb. 2014, doi: https:\/\/doi.org\/10.1016\/J.JVIR.2013.10.056.","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"8","key":"4410_CR43","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ejrad.2016.05.020","volume":"85","author":"L Beuzit","year":"2016","unstructured":"L. Beuzit et al., \u2018Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT)\u2019, Eur J Radiol, vol. 85, no. 8, pp. 1445\u20131452, Aug. 2016, doi: https:\/\/doi.org\/10.1016\/j.ejrad.2016.05.020.","journal-title":"European Journal of Radiology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04410-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:07:47Z","timestamp":1730200067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04410-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4410"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04410-9","relation":{},"ISSN":["2366-0058"],"issn-type":[{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}